Intra-class correlation (ICC) | Median Odds Ratio (MOR) | Variables | Adjusted OR (95% CI) | p | |
---|---|---|---|---|---|
Adherence to good clinical practice criteria in clinical evaluation (≥3 criteria fulfilled) | |||||
Empty model 1 | 0.36670 | 3.73040 | |||
Model 2: center variables1 | 0.31866 | 3.26487 | |||
Model 3: patient variables2 | 0.36831 | 3.74755 | |||
Full model 4 (center and patient) | 0.31850 | 3.26345 | Large hospital | 0.40 (0.21–0.79) | 0.008 |
Outpatient respiratory nursing clinic available | 2.47 (1.26–4.83) | 0.008 | |||
Active smokers | 1.32 (1.10–1.58) | 0.003 | |||
Charlson index ≥3 | 1.35 (1.15–1.59) | < 0.001 | |||
Number of hospital admissions in the last year ≥1 | 6.33 (5.02–7.98) | < 0.001 | |||
GesEPOC phenotype | |||||
Not exacerbator (reference) | |||||
Exacerbator | 0.79 (0.61–1.101) | 0.063 | |||
Missing | 0.36 (0.29–0.44) | < 0.001 | |||
To be taken care in specialized COPD outpatient clinic) | 2.10 (1.56–2.72) | < 0.001 | |||
1: included variables in the final center model: large hospital and outpatient respiratory nursing clinic available 2: included variables in the final patient model: active smokers, Charlson index ≥3, number of hospital admissions in the last year ≥1, to be taken care in specialized COPD outpatient clinic and GesEPOC phenotype exacerbator. | |||||
Adherence to good clinical practice criteria in COPD evaluation (≥4 criteria fulfilling) | |||||
Empty model 1 | 0.30343 | 3.13266 | |||
Model 2: center variables1 | 0.26684 | 2.83994 | |||
Model 3: patient variables2 | 0.29100 | 3.02953 | |||
Full model 4 (center and patient) | 0.24413 | 2.67316 | Respiratory ward not available (reference) | ||
Respiratory ward < 20 beds | 7.09 (2.53–9.90) | < 0.001 | |||
Respiratory ward ≥20 beds | 3.00 (1.37–6.60) | 0.006 | |||
Age ≤ 55 | 1.58 (1.19–2.09) | 0.001 | |||
Sex (male) | 0.77 (0.61–0.96) | 0.022 | |||
Charlson index ≥3 | 0.80 (0.68–0.94) | 0.008 | |||
FEV1 < 50% | 1.68 (1.42–1.99) | < 0.001 | |||
Dyspnea (MRC-m) | |||||
0–1 (reference) | |||||
≥ 2 | 1.39 (1.13–1.72) | 0.002 | |||
Missing | 0.69 (0.51–0.93) | 0.017 | |||
Level of dyspnea not referred to | 0.65 (0.49–0.86) | 0.003 | |||
GesEPOC phenotype | |||||
Non-exacerbator (reference) | |||||
Exacerbator | 1.16 (0.93–1.44) | 0.185 | |||
Missing | 0.17 (0.14–0.21) | < 0.001 | |||
Treatment at a specialized COPD outpatient clinic | 3.25 (2.49–4.23) | < 0.001 | |||
1: variables included in the final center model: in-patient respiratory clinic ≥20 present and specialized COPD outpatient clinic available. 2: variables included in the final patient model: age ≤ 55, gender (male), Charlson index ≥3, FEV1 < 50%, dyspnea, GesEPOC exacerbator phenotype and being treated in specialized COPD outpatient clinic. | |||||
Adherence to good clinical practice criteria in therapeutic intervention (≥3 criteria fulfilled) | |||||
Empty model 1 | 0.52169 | 6.09155 | |||
Model 2: center variables1 | 0.46935 | 5.08927 | |||
Model 3: patient variables2 | 0.49994 | 5.64024 | |||
Full model 4 (center and patient) | 0.44731 | 4.74211 | University hospital | 0.26 (0.08–0.85) | 0.026 |
Outpatient respiratory nursing clinic availability | 3.69 (1.50–9.11) | 0.005 | |||
Age ≤ 55 | 0.60 (0.42–0.86) | < 0.005 | |||
Sex (male) | 0.72 (0.55–0.93) | 0.014 | |||
Charlson index ≥3 | 1.19 (0.99–1.42) | 0.062 | |||
Number of hospital admissions in the last year ≥1 | 1.71 (1.38–2.11) | < 0.001 | |||
GesEPOC phenotype | |||||
Non-exacerbator (reference) | |||||
Exacerbator | 0.90 (0.71–1.15) | 0.404 | |||
Missing | 0.36 (0.29–0.46) | < 0.001 | |||
Treatment at a specialized COPD outpatient clinic | 2.61 (2.01–3.40) | <0.001 | |||
1: variables included in the final center model: university hospital and outpatient respiratory nursing clinic availability 2: variables included in the final patient model: age ≤ 55, gender (male), Charlson index ≥3, number of hospital admissions in the last year ≥1, GesEPOC exacerbator phenotype and being treated in specialized COPD outpatient clinic |